The first 3d printed audiology device has been launched by our partners Pro3dure at the 67th International Congress of Hearing Aid Acousticians hat benefits from th power of the Remora technology to inhibit biofilms.
This marks another milestone in the development of medical devices benefiting from Remora in the Multi Species Inhibition formulation developed by world experts in 3d medical printing Pro3dure, our licence partner in this field.
Building on our announcement of the license deal in April, we are very pleased to announce a further advance in the use of the Remora technology in the medical space. Our partners Pro3dure have perfected the incorporation of their MSI technology (multi species inhibition) in the Audiology market. With over 5% of population of the world suffering from disabling hearing loss, and many more affected by partial loss, there is a growing need for safe effective and comfortable solutions to this problem. Hearing assist devices that are commonly used in the target population group (often over 65 years of age) are effective, but prolonged use of these devices may cause ear infections. For the first time there is now a 3D printed option offered by Pro3dure that matches the profile and ergonomics of the patients ear and offers the novel benefits from the incorporation of MSI technology. As with the dental devices, Pro3dure’s world leading expertise in 3d printing in medical devices has enabled a first to market solution. This is a rapidly growing sector reflecting market pull from an ageing global population and the drive to support quality of life in older age.